Agilent Technologies Inc. Introduces New Cannabis and Hemp Potency and Pesticide/Mycotoxin Testing Solutions
Agilent Technologies Inc. recently announced new solutions for the cannabis and hemp testing markets.
Agilent Technologies Inc. recently announced new solutions for the cannabis and hemp testing markets. The Agilent eMethods product, Cannabis and Hemp Potency Kit, and Cannabis Pesticide and Mycotoxin Kit help testing laboratories create easy and effective solutions to get them running quickly.
In the company’s press release (1) they stated that “developing reliable testing protocols for complex matrices such as cannabis and hemp is arduous and time-consuming, especially for newer laboratories.” The Agilent eMethods product reportedly administers downloadable ready-to-run instrumental methods with an end-to-end workflow that addresses different testing needs and also offers guidance on sample preparation, consumables, and supplies. Aside from those benefits, the program also yields a complete analytical system configuration for automation, sample introduction, separation, detection, and is enabled with data processing and reporting capabilities.
“The fledgling market of cannabis and hemp testing has an urgent need for solutions that help ensure efficiency as well as regulatory compliance,” said Monty Benefiel, Agilent Vice President, and General Manager of the Mass Spectrometry Division (1). “Our new tool—Agilent eMethods—along with the Cannabis and Hemp Potency Kit and Cannabis Pesticide and Mycotoxin Kit gives labs a head start in establishing testing procedures, increasing productivity and profitability, and greatly reducing risk.”
Agilent’s new solutions support laboratories by providing fast setup and simplification of the analysis of the complex matrices that are involved with cannabis and hemp testing. Beginning with sample preparation all the way through to testing, these kits will reportedly allow laboratories to better navigate diverse regulations, which helps them stay up-to-date and compliant.
Reference
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
Assessing Cannabis as a Harm Reduction Strategy: Insights from a Large-Scale Study
November 19th 2024A New Zealand study aimed to assess cannabis use as a harm reduction tool. Findings highlight lifestyle factors, and suggest cannabis-focused harm reduction strategies in reducing other substance use such as alcohol.
Ep 23, Part III: Accreditation in the Cannabis Industry with Susan Audino
October 24th 2024In Part III of this episode, host Evan Friedmann is joined by Susan Audino, PhD, founder of S.A. Audino & Associates, LLC, and co-founder of Saturn Scientific, LLC, to examine the complexities of sampling in the cannabis industry, emphasizing the need for proper sampling plans, and methods.
